Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 37 of Equillium, Inc.'s SEC filings and found 7 warrant series, 1 ATM program, 4 shelf registrations and 3 completed offerings on file for EQ. The latest dilution event on file is an offering on Oct 26, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
ANIXAnixa Biosciences, Inc.
HURATuHURA Biosciences, Inc.
BDTXBlack Diamond Therapeutics, Inc.
LENZLENZ Therapeutics, Inc.
OTLKOutlook Therapeutics, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
KZIAKazia Therapeutics Limited American Depositary Shares
PYPDPolyPid Ltd. Ordinary Shares
NRXPNRx Pharmaceuticals, Inc.
ENGNenGene Holdings Inc.
IMUXImmunic, Inc.
VYGRVoyager Therapeutics, Inc.
AVXLAnavex Life Sciences Corp.
OKUROnKure Therapeutics, Inc.
CDXSCodexis, Inc.